Janssen Pharma (JNJ) Plans to Gain FDA Approval for 10 New Products by 2019
Go back to Janssen Pharma (JNJ) Plans to Gain FDA Approval for 10 New Products by 2019| Johnson & Johnson (NYSE: JNJ) | Delayed: 146.79 -1.74 (1.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $148.53 | 52 Week High | $126.07 | |||
| Open | $149.37 | 52 Week Low | $94.28 | |||
| Day High | $149.58 | P/E | 30.52 | |||
| Day Low | $146.55 | EPS | $4.81 | |||
| Volume | 1,520,333 | |||||
